Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis (Q39399689)

11 September 2017

Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis (English)

1 reference

11 September 2017

Sanguisorba officinalis

object named as

Sanguisorba officinalis

1 reference

ZhiYu Wang

1

1 reference

11 September 2017

Wings T Y Loo

2

1 reference

11 September 2017

Neng Wang

3

1 reference

11 September 2017

Louis W C Chow

4

1 reference

11 September 2017

Dongmei Wang

5

1 reference

11 September 2017

Feng Han

6

1 reference

11 September 2017

Xiao Zheng

7

1 reference

11 September 2017

Jian-Ping Chen

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

9 February 2012

1 reference

Expert Opinion on Therapeutic Targets

11 September 2017

1 reference

11 September 2017

16 Suppl 1

1 reference

11 September 2017

S79-89

1 reference

Herceptin and breast cancer: an overview for surgeons

11 September 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Targeted therapy in the treatment of solid tumors: practice contradicts theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Medicinal plants and cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

From traditional Chinese medicine to rational cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Triterpenoids from Sanguisorba officinalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Inhibition of DNA Topoisomerases by Sanguiin H-6, a Cytotoxic Dimeric Ellagitannin fromSanguisorba officinalis1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Angiogenesis inhibitors: current strategies and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

Cancer Therapy with Natural Products and Medicinal Plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2011.642371

10.1517/14728222.2011.642371

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference